NEW YORK (GenomeWeb News) – Trovagene today announced a clinical collaboration agreement with the University of Southern California for the use of the San Diego-based firm's cell-free DNA assays to genomically characterize metastatic colorectal cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.